New product intros [berotralstat hydrochloride, cetuximab sarotalocan, daratumumab sc (new indication), eptacog beta, coagulation factor VIIa-jncw, etesevimab, evinacumab-dgnb (first-in-class), human SARS-CoV-2 inactivated vaccine, inclisiran, orelabrutinib, relugolix (new indication), remogliflozin etabonate/vildagliptin (new combination), surufatinib, voclosporin]

2021 ◽  
Vol 57 (3) ◽  
pp. 241
Keyword(s):  
Factor Viia ◽  
Coagulation Factor ◽  
New Product ◽  
New Combination ◽  
Inactivated Vaccine ◽  
Remogliflozin Etabonate

A Novel Exosite on Coagulation Factor VIIa and Its Molecular Interactions with a New Class of Peptide Inhibitors‡

Biochemistry ◽  
2001 ◽  
Vol 40 (32) ◽  
pp. 9522-9531 ◽  
Author(s):  
Martin Roberge ◽  
Lydia Santell ◽  
Mark S. Dennis ◽  
Charles Eigenbrot ◽  
Mary A. Dwyer ◽  
...  
Keyword(s):  
Molecular Interactions ◽  
Factor Viia ◽  
Coagulation Factor ◽  
Peptide Inhibitors ◽  
New Class

scholarly journals Allostery in Coagulation Factor VIIa Revealed by Ensemble Refinement of Crystallographic Structures

2019 ◽  
Vol 116 (10) ◽  
pp. 1823-1835
Author(s):  
Anders B. Sorensen ◽  
Jesper J. Madsen ◽  
Thomas M. Frimurer ◽  
Michael T. Overgaard ◽  
Prafull S. Gandhi ◽  
...  
Keyword(s):  
Factor Viia ◽  
Coagulation Factor ◽  
Crystallographic Structures
Sign in / Sign up

Export Citation Format

Share Document